Erratum to "NIMROD: A program for inference via normal approximation of the posterior in models with random effects based on ordinary differential equations" [Comput. Methods Programs Biomed. 111 (2) (2013) 447-458], 10.1016/j.cmpb.2013.04.014;NIMROD: A program for inference via a normal approximation of the posterior in models with random effects based on ordinary differential equations

Computer Methods and Programs in Biomedicine

Volumn 111, Issue 2, 2013, Pages 447-458

  Prague, Mélanie ^a,b   Commenges, Daniel ^a,b   Guedj, Jérémie ^c   Drylewicz, Julia ^d,e   Thiébaut, Rodolphe ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

HIV; Maximum a posteriori; Maximum likelihood; Non linear mixed effects model; Ordinary differential equations; Pharmacokinetics

Indexed keywords

BAYESIAN NETWORKS; DYNAMICAL SYSTEMS; MAXIMUM LIKELIHOOD; MAXIMUM LIKELIHOOD ESTIMATION; PHARMACOKINETICS; RANDOM PROCESSES; STATISTICAL METHODS;

CONVERGENCE CRITERION; LEAVE-ONE-OUT CROSS VALIDATIONS; MAXIMUM A POSTERIORI; MAXIMUM LIKELIHOOD APPROACHES; NONLINEAR MIXED EFFECTS; ORDINARY DIFFERENTIAL EQUATION (ODE); PHARMACOKINETICS MODELS; POSTERIOR DISTRIBUTIONS;

ORDINARY DIFFERENTIAL EQUATIONS;

ALGORITHM; ANALYTICAL PARAMETERS; ARTICLE; BAYESIAN LEARNING; BIOAVAILABILITY; BLOOD LEVEL; COMPARTMENT MODEL; DRUG ABSORPTION; EXPLANATORY VARIABLE; MATHEMATICAL MODEL; MAXIMUM LIKELIHOOD METHOD; NONLINEAR REGRESSION ANALYSIS; ORDINARY DIFFERENTIAL EQUATION; PROBABILITY; REPRODUCIBILITY; SIMULATION;

EID: 84880046553     PISSN: 01692607     EISSN: 18727565     Source Type: Journal    
DOI: 10.1016/j.cmpb.2013.09.015     Document Type: Erratum

References (46)

1. Berger J. Statistical Decision Theory and Bayesian Analysis 1985, Springer, New York, USA.
2. Berndt E., Hall B., Hall R. Estimation and inference in nonlinear structural models. Annals of Economic and Social Measurement 1974, 3(4):103-116.
3. Box G., Tiao G. Bayesian Inference in Statistical Analysis 1973, Addison-Wesley Publishing Company, University of Michigan, USA.
4. Commenges D., Jacqmin-Gadda H., Proust C., Guedj J. A Newton-like Algorithm for Likelihood Maximization: The Robust-Variance Scoring Algorithm 2006, Arxiv math/0610402.
5. Commenges D., Joly P., Gégout-Petit A., Liquet B. Choice between semi-parametric estimators of markov and non-markov multi-state models from coarsened observations. Scandinavian Journal of Statistics 2007, 34(1):33-52.
6. Commenges D., Proust-Lima C., Samieri C., Liquet B. A Universal Approximate Cross-validation Criterion and its Asymptotic Distribution 2012, arXiv:1206.1753.
7. Commenges D., Sayyareh A., Letenneur L., Guedj J., Bar-Hen A. Estimating a difference of kullback-leibler risks using a normalized difference of AIC. Annals of Applied Statistics 2008, 2(3):1123-1142.
8. Ding A., Wu H. Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models. Biostatistics 2001, 2(1):13-29.
9. Drylewicz J., Commenges D., Thiébaut R. Score tests for exploring complex models: application to HIV dynamics models. Biometrical Journal 2010, 52(1):10-21.
10. Drylewicz J., Commenges D., Thiébaut R. Maximum a posteriori estimation in dynamical models of primary HIV infection. Statistical Communications in Infectious Diseases 2012, 4(1). (Online).
11. Drylewicz J., Guedj J., Commenges D., Thiébaut R. Modeling the dynamics of biomarkers during primary HIV infection taking into account the uncertainty of infection date. Annals of Applied Statistics 2010, 4(4):1847-1870.
12. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Analysis 2006, 1(3):515-533.
13. Genz A., Keister B. Fully symmetric interpolatory rules for multiple integrals over infinite regions with gaussian weight. Journal of Computational and Applied Mathematics 1996, 71(2):299-309.
14. Godfrey K., Jones R., Brown R. Identifiable pharmacokinetic models: the role of extra inputs and measurements. Journal of Pharmacokinetics and Pharmacodynamics 1980, 8(6):633-648.
15. Guedj J., Thiébaut R., Commenges D. Maximum likelihood estimation in dynamical models of HIV. Biometrics 2007, 63(4):1198-1206.
16. Guedj J., Thiébaut R., Commenges D. Practical identifiability of HIV dynamics models. Bulletin of Mathematical Biology 2007, 69(8):2493-2513.
17. Hindmarsh A. Odepack: A systematized collection of ode solvers. IMACS Transactions on Scientific Computations 1983, 1(1):55-64.
18. Jacqmin-Gadda H., Thiébaut R., Chêne G., Commenges D. Analysis of left-censored longitudinal data with application to viral load in HIV infection. Biostatistics 2000, 1(4):355-368.
19. Kass R., Steffey D. Approximate Bayesian inference in conditionally independent hierarchical models (parametric empirical Bayes models). Journal of the American Statistical Association 1989, 84(407):717-726.
20. Kuhn E., Lavielle M. Maximum likelihood estimation in nonlinear mixed effects models. Computational Statistics and Data Analysis 2005, 49(4):1020-1038.
21. Lindstrom M., Bates D. Nonlinear mixed effects models. Biometrics 1990, 46:673-687.
22. Louis T. Finding the observed information matrix when using the em algorithm. Journal of the Royal Statistical Society: Series B (Methodological) 1982, 44(2):226-233.
23. Marquardt D. An algorithm for least-squares estimation of nonlinear parameters. Journal of the Society for Industrial and Applied Mathematics 1963, 11(2):431-441.
24. Okusanya O., Forrest A., DiFrancesco R., Bilic S., Rosenkranz S., Para M., Adams E., Yarasheski K., Reichman R., Morse G., et al. Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrobial agents and chemotherapy 2007, 51(5):1822-1826.
25. Olofsen E., Dinges D.F., Van Dongen H. Nonlinear mixed-effects modeling: individualization and prediction. Aviation, Space, and Environmental Medicine 2004, 75(Supplement 1):A134-A140.
26. Pacheco P. Parallel Programming with MPI 1997, Morgan Kaufmann, San francisco, USA.
27. Perelson A., Neumann A., Markowitz M., Leonard J., Ho D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271(5255):1582-1586.
28. Pinheiro J., Bates D. Approximations to the log-likelihood function in the nonlinear mixed-effects model. Journal of Computational and Graphical Statistics 1995, 4(1):12-35.
29. Pinheiro J., Bates D. Mixed-effects Models in S and S-PLUS 2000, Springer Verlag, New York, USA.
30. Plan E., Maloney A., Mentré F., Karlsson M., Bertrand J. Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose response models. AAPS Journal 2012, 14(3):420-432.
31. Potra F., Shi Y. Efficient line search algorithm for unconstrained optimization. Journal of Optimization Theory and Applications 1995, 85(3):677-704.
32. Prague M., Commenges D., Drylewicz J., Thiébaut R. Treatment monitoring of HIV infected patients based on mechanistic models. Biometrics 2012, 68(3):902-911.
33. Prague M., Commenges D., Thiébaut R. Dynamical models of biomarkers and clinical progression for personalized medicine: the HIV context. Advanced Drug delivery Reviews 2013, http://dx.doi.org/10.1016/j.addr.2013.04.004(in press).
34. Radhakrishnan K., Hindmarsh A., Aeronautics U.S.N., Administration S. Description and use of LSODE, The Livermore Solver for Ordinary Differential Equations 1993, National Aeronautics and Space Administration, Office of Management, Scientific and Technical Information Program, Livermore National Laboratory & Lewis Research Center Group, Livermore, USA.
35. Raguin G., Chêne G., Morand-Joubert L., Taburet A., Droz C., Le Tiec C., Clavel F., Girard P., Group P.S., et al. Salvage therapy with amprenavir, lopinavir and ritonavir 200mg/d or 400mg/d in HIV-infected patients in virological failure. Antiviral Therapy 2004, 9:615-626.
36. Ramsay J., Hooker G., Campbell D., Cao J. Parameter estimation for differential equations: a generalized smoothing approach. Journal of the Royal Statistical Society: Series B: Statistical Methodology 2007, 69(5):741-796.
37. Rosenbaum S. Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook and Computer Simulations 2011, Wiley, Hoboken, New Jersey, USA.
38. Rue H., Martino S., Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. Journal of the Royal Statistical Society: Series B: Statistical Methodology 2009, 71(2):319-392.
39. Sadler B., Piliero P., Preston S., Lloyd P., Lou Y., Stein D. Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers. Aids 2001, 15(8):1009.
40. Sale M., Sadler B., Stein D. Pharmacokinetic modeling and simulations of interaction of amprenavir and ritonavir. Antimicrobial Agents and Chemotherapy 2002, 46(3):746-754.
41. Van der Vaart A. Asymptotic Statistics 2000, Cambridge Univ. Pr., Cambridge, UK.
42. Verbeke G., Molenberghs G. Linear Mixed Models for Longitudinal Data 2009, Springer Verlag, New York, USA.
43. Wakefield J., Racine-Poon A. An application of bayesian population pharmacokinetic/pharmacodynamic models to dose recommendation. Statistics in Medicine 1995, 14(9):971-986.
44. Wang L., Cao J., Ramsay J., Burger D., Laporte C., Rockstroh J. Estimating mixed-effects differential equation models. Statistics and Computing 2012, 1-11.
45. Wang Y. Derivation of various nonmem estimation methods. Journal of Pharmacokinetics and Pharmacodynamics 2007, 34(5):575-593.
46. Welham S., Cullis B., Kenward M., Thompson R. A comparison of mixed model splines for curve fitting. Australian and New Zealand Journal of Statistics 2007, 49(1):1-23.